The trademark application was filed by Millennium Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on August 26, 2021, and it was registered by office on December 3, 2021 without any oppositions.
The application was filed in English (German was selected as the second language).